Xenetic Biosciences, Inc. - 8-K Filing

Xenetic Biosciences announces Q3 2026 results and provides updates regarding a proposed share exchange transaction with Santersus AG. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 13, 2026, 13:35 UTC

Tickers: $XBIO

Read the full article at SEC EDGAR

Part of the story Jade Biosciences, Inc. - 10-Q Filing (2 articles)

More Regulatory news

Evolution Metals & Technologies Corp. - 8-K Filing SEC EDGAR · November 13, 2026, 13:38 UTC
Virgin Galactic Holdings, Inc - 8-K Filing SEC EDGAR · November 13, 2026, 13:39 UTC
Suncrete, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 13:36 UTC
TANDEM DIABETES CARE INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:35 UTC
COMMVAULT SYSTEMS INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
Indaptus Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 13:30 UTC
Katapult Holdings, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 13:30 UTC
GOODYEAR TIRE & RUBBER CO /OH/ - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
BIO KEY INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
Loop Industries, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC